Zoetis Launches New Versican Plus Canine Vaccine Range
9 years ago 
34037 views
Zoetis UK Ltd has introduced Versican® Plus, a new comprehensive vaccine range for dogs in the UK and throughout Europe. Versican Plus is the only vaccine to combine DHPPi + L4 in a single injection1, the result of several years of innovative research and development.
The leptospirosis components of this modern vaccine have been designed to meet the challenges of both existing and emerging types. Versican Plus is the only tetravalent leptospirosis vaccine to deliver prevention against clinical signs and urinary excretion of established (Icterohaemorragiae and Canicola) and emerging (Bratislava and Grippotyphosa) canine leptospirosis (except Grippotyphosa where prevention of clinical signs occurs but with a reduction in urinary excretion).
Another advantage this vaccine brings is in its viral components. Versican Plus utilises a new CPV-2b strain, the most prevalent strain in the UK2, to prevent clinical signs, leucopoenia and viral excretion caused by Parvovirus.
Practices using Versican Plus will have the ability to provide protection at the earliest opportunity, as it has been proven to be protective against virulent challenge in the presence of maternally derived antibodies to Parvovirus, Distemper and Adenovirus at levels equal or higher to those likely to be encountered under field conditions. As a result Versican Plus can be used from 6 weeks of age with an important early onset of immunity being achieved for Parvovirus, Distemper and Adenovirus at 9 weeks. Parainfluenza and Leptospirosis immunity follow shortly thereafter at 12 and 13 weeks respectively.
Moreover following primary vaccinations three to four weeks apart Versican Plus provides 3 years duration of immunity for Parvovirus, Distemper and Adenovirus.
Ned Flaxman, Zoetis UK Companion Animal director said, “Our research and development team has taken many different aspects of vaccination into account to create Versican Plus. As well as offering comprehensive protection in accordance with the current epidemiological situation, the vaccine is also convenient to use. It offers a flexible primary vaccination course with an early finish option from 9 weeks, important for early socialisation reasons.”
Further information available at www.zoetis.co.uk/versicanplus or contact your Zoetis Account Manager or telephone 0845 300 8034.
References
1 Versican Plus Summary of Product Characteristics
2 Davies M. Canine Parvovirus strains identified from critically ill dogs in the United Kingdom. Veterinary Record (2008) 163, 543-545
More from Zoetis
- Zoetis appoints new Inside Sales Account Manager
- Zoetis Equip® Artervac Supply Issue
- Zoetis UK Appoints Simon Dunne as Companion Animal Business Unit Director
- Zoetis UK: Update On The Supply Of Equip® Rotavirus
- Zoetis UK and StreetVet Announce Charity of the Year Partnership to Further Support the Human Animal Bond
23 hours ago